Ravelcare IPO Subscription Status; IPO Subscribed 81.55 Times on Day 2

Mumbai, December 2:Ravelcare IPO has seen overwhelming investor interest on its second day of bidding, with a total subscription status of 81.55 times as of 5:09 PM. 

Individual investors are leading the charge, subscribing 95.47 times with bids for 5.92 crore shares against 6.20 lakh shares on offer. Non-Institutional Buyers (NII) have shown exceptionally strong demand, subscribing 148.16 times with bids for 3.91 crore shares against 2.64 lakh shares available, with bulk NII bids (above ₹10 lakh) contributing 2.74 crore shares and smaller NII bids accounting for 1.17 crore shares. 

Qualified Institutional Buyers (QIBs, excluding anchors) subscribed 6.86 times, bidding for 24.07 lakh shares against 3.51 lakh shares on offer, while anchor investors and market makers fully subscribed their allocations of 5.25 lakh and 94,000 shares, respectively.

In total, the IPO received bids for 10.07 crore shares against 12.35 lakh shares on offer, raising ₹1,309.28 crore across 36,808 applications. The strong participation from both retail and institutional investors underscores high market enthusiasm for the issue, with final allotment and listing expected in the coming days.

Ravelcare Business Profile 

Ravelcare Limited is an Indian Direct to Consumer (D2C) brand in the Beauty and Personal Care (BPC) sector, operating primarily under the brand name Ravel. The company focuses on offering customised, data-driven, and standard BPC products. The products are sold through a Direct to Consumer (D2C) approach via their own website and major online marketplaces like Amazon, Flipkart, Myntra, and quick commerce platforms like Blinkit. The company promotes cruelty-free, sulfate-free, paraben-free, alcohol-free, toxin-free, and GMO-free formulations. The company was established in 2018, and is headquartered in Mumbai, Maharashtra. 

Key Details About Ravelcare IPO

The ₹24.10 crore Ravelcare IPO is entirely a fresh issue of 0.19 crore shares of ₹24.10 crore. Ravelcare IPO price band is at ₹123 to ₹130 per share. The lot size is 1,000 shares per application. The minimum investment amount required by a retail investor is at ₹2,60,000 (2,000 shares) at the upper price band. The minimum lot size investment for HNI is 3 lots (3,000 shares), amounting to ₹3,90,000. Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is SS Corporate Securities Ltd.

Ravelcare IPO Financial Highlights 

As of 30 September 2025, the company reported assets of ₹15.68 crore, total income of ₹14.44 crore, profit after tax of ₹3.20 crore, EBITDA of ₹4.33 crore, net worth of ₹13.55 crore, reserves and surplus of ₹8.54 crore, and total borrowing of ₹0 crore. For the year ended 31 March 2025, the company had assets of ₹11.63 crore, total income of ₹25.30 crore, profit after tax of ₹5.26 crore, EBITDA of ₹6.82 crore, net worth of ₹10.35 crore, reserves of ₹5.35 crore, and total borrowing of ₹0.04 crore.

What’s Ahead for Ravelcare IPO?

Ravelcare IPO has entered its second day of bidding, and the IPO issue will close on December 3. The allotment status for Ravelcare IPO is expected to be finalised on December 4. The company is expected to credit the shares and initiate refunds on December 5. The shares of the company are expected to list on BSE SME on December 8. 

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations